The molecular mechanisms involved in the neurodegenerative process of Parkinson's disease remain unclear. Currently, there is a general agreement that mitochondrial dysfunction, α-synuclein aggregation, oxidative stress, neuroinflammation, and impaired protein degradation are involved in the neurodegeneration of dopaminergic neurons containing neuromelanin in Parkinson's disease. Aminochrome has been proposed to play an essential role in the degeneration of dopaminergic neurons containing neuromelanin by inducing mitochondrial dysfunction, oxidative stress, the formation of neurotoxic α-synuclein protofibrils, and impaired protein degradation. Here, we discuss the relationship between the oxidation of dopamine to aminochrome, the precursor ...
Four decades after L-dopa introduction to PD therapy, the cause of Parkinson's disease (PD) remains ...
L-Dopa continues to be the gold drug in Parkinson's disease ( PD) treatment from 1967. The failure t...
Artículo de publicación ISIThe molecular mechanisms causing the loss of dopaminergic neurons contai...
Copyright © 2012 Patricia Muñoz et al. This is an open access article distributed under the Creativ...
Mitochondrial and lysosomal dysfunction have been implicated in substantia nigra dopaminergic neurod...
In 1967, L-dopa was introduced as part of the pharmacological therapy of Parkinson's disease (PD) an...
L-Dopa continues to be the gold drug in Parkinson's disease ( PD) treatment from 1967. The failure t...
The preferential degeneration of dopaminergic neurons in the substantia nigra pars compacta is respo...
Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Park...
The preferential degeneration of dopaminergic neurons in the substantia nigra pars compacta is respo...
Aminochrome, the precursor of neuromelanin, has been proposed to be involved in the neurodegeneratio...
Parkinson’s disease, like other neurodegenerative diseases, exhibits two common features: Prot...
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are generated primarily from endog...
Autophagy is the mechanism through which cells degrade oxidized membranes-organelles and mis/unfolde...
Autophagy is the mechanism through which cells degrade oxidized membranes-organelles and mis/unfolde...
Four decades after L-dopa introduction to PD therapy, the cause of Parkinson's disease (PD) remains ...
L-Dopa continues to be the gold drug in Parkinson's disease ( PD) treatment from 1967. The failure t...
Artículo de publicación ISIThe molecular mechanisms causing the loss of dopaminergic neurons contai...
Copyright © 2012 Patricia Muñoz et al. This is an open access article distributed under the Creativ...
Mitochondrial and lysosomal dysfunction have been implicated in substantia nigra dopaminergic neurod...
In 1967, L-dopa was introduced as part of the pharmacological therapy of Parkinson's disease (PD) an...
L-Dopa continues to be the gold drug in Parkinson's disease ( PD) treatment from 1967. The failure t...
The preferential degeneration of dopaminergic neurons in the substantia nigra pars compacta is respo...
Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Park...
The preferential degeneration of dopaminergic neurons in the substantia nigra pars compacta is respo...
Aminochrome, the precursor of neuromelanin, has been proposed to be involved in the neurodegeneratio...
Parkinson’s disease, like other neurodegenerative diseases, exhibits two common features: Prot...
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are generated primarily from endog...
Autophagy is the mechanism through which cells degrade oxidized membranes-organelles and mis/unfolde...
Autophagy is the mechanism through which cells degrade oxidized membranes-organelles and mis/unfolde...
Four decades after L-dopa introduction to PD therapy, the cause of Parkinson's disease (PD) remains ...
L-Dopa continues to be the gold drug in Parkinson's disease ( PD) treatment from 1967. The failure t...
Artículo de publicación ISIThe molecular mechanisms causing the loss of dopaminergic neurons contai...